Blood marker may reveal hidden bone damage in myeloma patients
NCT ID NCT02800954
First seen Nov 19, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study looked at whether a substance in the blood called M-CSF can help doctors find bone damage caused by multiple myeloma. Researchers compared M-CSF levels in 111 people: those with multiple myeloma, those with a pre-cancer condition called MGUS, and healthy volunteers. The goal was to see if M-CSF could be a useful marker for bone lesions, but no treatment was tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Beauvais
Beauvais, 60021, France
-
CHU Amiens
Amiens, 80054, France
-
Ch Saint Quentin
Saint-Quentin, 02321, France
Conditions
Explore the condition pages connected to this study.